Rapid and Sensitive Detection of SARS-CoV-2 Using Clustered Regularly Interspaced Short Palindromic Repeats
Open Access
- 27 February 2021
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 9 (3), 239
- https://doi.org/10.3390/biomedicines9030239
Abstract
Rapid and accurate detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential for controlling the pandemic of coronavirus disease 2019. Polymerase chain reaction (PCR)-based technique is the standard test for detection of SARS-CoV-2, which, however, requires complicated sample manipulation (e.g., RNA extraction) and is time-consuming. We previously demonstrated that clustered regularly interspaced short palindromic repeats (CRISPR) could precisely detect Human papillomavirus and somatic mutations of Epidermal growth factor receptor gene and Kirsten rat sarcoma viral oncogene homolog gene in plasma. The objective of this study was to develop CRISPR as a rapid test for sensitive detection of SARS-CoV-2. We first combined reverse transcription-isothermal recombinase polymerase amplification and CRSIPR to detect SARS-CoV-2 in genomic RNA of cells infected with the virus. The CRISPR assay with guide RNA against the M gene of SARS-CoV-2 had a sensitivity of 0.1 copies per µL for detection of the virus. We then used the CRSIPR assay to directly analyze raw SARS-CoV-2 samples. The CRISPR assay could sensitively detect SARS-CoV-2 in one hour without RNA extraction. This assay can be performed at a single temperature and with minimal equipment. The results were immediately visualized either by a UV light illuminator or paper strips. The diagnostic value of the test was confirmed in nasopharyngeal swab specimens. Altogether, we have developed a rapid CRISPR test for sensitive detection of SARS-CoV-2.This publication has 25 references indexed in Scilit:
- Repurposing CRISPR-Cas12b for mammalian genome engineeringCell Discovery, 2018
- Next-generation diagnostics with CRISPRScience, 2018
- Field-deployable viral diagnostics using CRISPR-Cas13Science, 2018
- CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activityScience, 2018
- Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6Science, 2018
- TUFT1 interacts with RABGAP1 and regulates mTORC1 signalingCell Discovery, 2018
- RNA targeting with CRISPR–Cas13Nature, 2017
- Nucleic acid detection with CRISPR-Cas13a/C2c2Science, 2017
- Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detectionNature, 2016
- The roles of CRISPR–Cas systems in adaptive immunity and beyondCurrent Opinion in Immunology, 2015